TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Chiron Pharmasynth AS
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
1,397
|
934
|
886 |
Financial expenses |
12
|
13
|
12 |
Earnings before taxes |
180
|
386
|
470 |
Total assets |
2,703
|
2,561
|
2,060 |
Current assets |
2,703
|
2,561
|
2,059 |
Current liabilities |
1,034
|
979
|
687 |
Equity capital |
1,670
|
1,581
|
1,373 |
- share capital |
169
|
178
|
169 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
61.8%
|
61.7%
|
66.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
12.9%
|
41.3%
|
53.0% |
Return on assets (ROA) |
7.1%
|
15.6%
|
23.4% |
Current ratio |
261.4%
|
261.6%
|
299.7% |
Return on equity (ROE) |
10.8%
|
24.4%
|
34.2% |
Change turnover |
512
|
0
|
-158 |
Change turnover % |
58%
|
0%
|
-15% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.